0HD2.L
Price:
$315.3999
Market Cap:
$41.06B
Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics based on ribonucleic acid interference. The company's pipeline of investigational RNAi therapeutics focuses on genetic medicines, cardio-metabolic diseases, hepatic infectious diseases, and central nervous system (CNS)/ocular diseases. Its marketed products include ONPATTRO (patisiran), a lipid complex injection for the treatment of the polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; GIVLAARI for the treatment of adults with acute hepatic porphyria (AHP); and OXLUMO (lumasiran) for the treatment of primary hyperoxaluria type 1 (PH1)...[Read more]
Industry
Medical - Pharmaceuticals
IPO Date
2018-01-29
Stock Exchange
LSE
Ticker
0HD2.L
Dividends are a key part of long-term returns for investors, and Alnylam Pharmaceuticals, Inc. (0HD2.L) has a track record worth reviewing. Looking at dividend history for 0HD2.L gives you an idea of how consistent the dividends have been and what you might expect in the future.
Ex-Dividend Date
2022-03-15
Dividend Yield
0%
Annual Dividend
$0.28
P/E Ratio
-42.11
Payout Ratio
0
Dividend per Share
$0
EPS
-7.49
Ex-Date/EFF Date | Dividend Amount | Adjusted Dividend | Payment Date | Declaration Date |
---|---|---|---|---|
2022-03-15 | $0.285 | $0.285 |
The table below shows Alnylam Pharmaceuticals, Inc. (0HD2.L) dividend history over the years, including the amount per share, the payout date, and any adjustments for stock splits.
Alnylam Pharmaceuticals, Inc. (0HD2.L) dividend history also allows you to track its dividend growth over time. This gives you insight into how the company’s earnings and payout ratios have evolved. Tracking this growth can help you gauge the stock's potential for future income.
Check out the dividend history of other popular stocks:
Stock name | Dividend yield |
---|
Tracking and finding valuable dividend stocks to invest in is difficult. For this, you can use Wisesheets, which allows you to pull all necessary dividend, financial, and price data to track your dividend investments in one place exactly how you want, using the power of spreadsheets.
You can build any custom analysis dashboards, screeners and trackers with no code and analyze companies like Alnylam Pharmaceuticals, Inc. (0HD2.L) without the pain and hassle of copy pasting data.
What is dividend history?
How do I check past dividend history?
What does the ex-dividend date mean?
What is 0HD2.L’s dividend yield?
What is the difference between regular and special dividends?
Has 0HD2.L increased its dividends over time?
Why might dividend history data be delayed?
How often does 0HD2.L pay dividends?
What factors impact 0HD2.L's dividend payments?
Can dividends change over time?
What is 0HD2.L’s next dividend date?